Primary Hyperoxaluria Mutation Genotyping/Phenotyping

NCT02340689 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1235

Last updated 2019-08-19

No results posted yet for this study

Summary

Specific mutations relating to hyperoxaluria will be determined via DNA analysis by the Mayo RKSC research staff.

Conditions

  • Primary Hyperoxaluria

Interventions

OTHER

Genetic Analysis

We will draw one tube of blood from your arm to obtain white blood cells. These white blood cells will be used as a source of DNA for genetic analysis.

Sponsors & Collaborators

Principal Investigators

  • Dawn Milliner, MD · Mayo Clinic

Eligibility

Min Age
1 Day
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02340689 on ClinicalTrials.gov